...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: New SEDAR page
4
Aug 02, 2023 02:29PM

Aug 03, 2023 11:06AM
3
Aug 03, 2023 11:47AM
1
Aug 06, 2023 07:54AM
1
Aug 08, 2023 12:41PM
1
Aug 08, 2023 04:16PM

What "visible profile" is Chris referring to?

 

Koo


Aug 10, 2023 12:55PM
Share
New Message
Please login to post a reply